Nicoracetam
1-(6-methoxypyridine-3-carbonyl)pyrrolidin-2-one
Nicoracetam is a rare racetam derivative with a pyrrolidone backbone and a methoxypyridine moiety, referenced in chemical registries but never formally studied in animals or humans.
Also known as:
Formula
C₁₁H₁₂N₂O₃
Category
Racetam / Pyridine-acyl
Molar Mass
220.22 g/mol
Legal Status
Unapproved, research only
Chemical Profile
Mechanism of Action
No mechanism studies or animal experiments have been published. Presumed to be a classic racetam-structured CNS modulator, but no in vitro or in vivo research is available.
Registry & Patent Literature Only
No Published Preclinical or Clinical Data
Nicoracetam is registered in major chemical, patent, and pharmaceutical substance databases, but no experimental data or claims are published in PubMed or similar biomedical sources as of 2024.
Safety & Side Effects
No animal, in vitro, or clinical data exists regarding toxicity or adverse effects of Nicoracetam.
Regulatory & Legal Status
US/EU/International
- Never scheduled or approved by any regulatory body
- Not marketed; appears in chemical registries
- Research chemical only; not for human use
Note: Not approved, only for laboratory/research use.
History
Nicoracetam is a chemical curiosity of the racetam family, likely synthesized late 20th century, included in registry and patent databases but never progressed to published pharmacological, animal, or clinical investigation.
Premium Nicoracetam
Enhance your cognitive performance with science-backed, high-quality nootropics.
Benefits
- Unique pyridine-acyl racetam structure
- Referenced in chemical and patent databases
- Potential for SAR and chembio research
Considerations
- No animal/human research has been published
- Never marketed or FDA/EMA approved
- Not for human use
Free shipping on orders above $50
Scientific References
- "Nicoracetam." PubChem Compound Summary, NCBI, CID 3047790, 2024. https://pubchem.ncbi.nlm.nih.gov/compound/3047790.
- "Nicoracetam." ChEMBL Compound Report Card, CHEMBL2104757, EBI, 2024. https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2104757/
- Patent structure reference for Nicoracetam (WIPO Patentscope).
For research/educational reference only. Not for human use. Last updated: 4/12/2025.